Progress in the treatment of acute myeloid leukemia

Ravandi, Farhad, Burnett, Alan Kenneth, Agura, Edward D. and Kantarjian, Hagop M. 2007. Progress in the treatment of acute myeloid leukemia. Cancer 110 (9) , pp. 1900-1910. 10.1002/cncr.23000

Full text not available from this repository.

Abstract

Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regimens combining cytotoxic agents for the treatment of patients with AML. Current research is attempting to better stratify patients by identifying risk factors responsible for resistance, and to discern ways for incorporating newer agents with specific and targeted activity into our standard regimens, Herein the recent developments in the diagnosis and treatment of AML are reviewed.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Elsevier
ISSN:	0008-543X
Last Modified:	25 Jun 2017 04:41
URI:	https://orca.cardiff.ac.uk/id/eprint/58484

Citation Data

Cited 64 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item